newsfilter
← Latest News
Business Wire·

Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health

● The study marks Click's second active randomized clinical trial testing digital interventions in migraine patients. ● The ReMMiD-C trial will evaluate the efficacy and safety of investigational digital therapeutics